EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: July 2019

Epidarex Co-founder and Managing Partner Kyp Sirinakis Joins TEDCO’s New Task Force for Women Entrepreneurs

July 24, 2019

Epidarex co-founder and managing partner Kyp Sirinakis has joined TEDCO’s new Task Force for Women Entrepreneurs. The task force is dedicated to the recruitment, funding,

Read »

Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer

July 22, 2019

CRESTWOOD, Ky. and WALTHAM, Mass., – Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease

Read »

Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies

July 18, 2019

Read »

EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: July 2019

Epidarex Co-founder and Managing Partner Kyp Sirinakis Joins TEDCO’s New Task Force for Women Entrepreneurs

Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer

Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies

Categories

Archives